AbbVie Inc. Financial Report: Common Stock & Senior Notes Overview

The provided XML section appears to be an excerpt from a financial report related to AbbVie Inc., specifically detailing its securities listed on exchanges and certain senior notes. Here are the key insights extracted from the information:

1. Entity Identification:

• Company Name: AbbVie Inc.
• CIK Number: 0001551152
• SEC Central Index Key (CIK) is a unique identifier for filings.

2. Common Stock Information:

• Type: Common Stock
• Par Value: $0.01
• Ticker Symbol: ABBV
• Listed on: NYSE (New York Stock Exchange)

3. Senior Notes:

• The report mentions several series of Senior Notes, which are debt securities issued by AbbVie. The specifics are as follows:
• • 0.750% Senior Notes due 2027: Ticker ABBV27
  • 2.125% Senior Notes due 2028: Ticker ABBV28
  • 2.625% Senior Notes due 2028: Ticker ABBV28B
  • 2.125% Senior Notes due 2029: Ticker ABBV29
  • 1.250% Senior Notes due 2031: Ticker ABBV31

4. Reporting Date:

• The information is relevant as of February 13, 2025, indicating a snapshot of the company’s financial instruments at that specific date.

5. Exchange Listings:

• The common stock and senior notes are listed on the NYSE (New York Stock Exchange) and CHX (Chicago Stock Exchange).

6. Structural Context:

• The report uses XBRL (eXtensible Business Reporting Language) for structured financial reporting, which allows for enhanced data extraction, analysis, and transparency.

7. Contact Information:

• AbbVie’s headquarters is located at 1 North Waukegan Road, North Chicago, IL 60064-6400, with a contact number provided.

This summary highlights the company’s equity structure and its debt obligations, essential for assessing financial health, investor interest, and overall market positioning. Understanding these securities is crucial for investors looking to gauge AbbVie’s financial stability and future performance.